IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q4 2020 Holdings

Filed 2021-02-16 | 12 holdings | $219.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$157.4M643,00071.9%
BioCryst Pharmaceuticals Inc(BCRX)COM09058V103$60.9M8,175,00027.8%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$159.9K14,040,0000.1%
Alkermes PLC(ALKS)SHSG01767105$158.6K7,950,0000.1%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$153.2K928,1000.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$124.6K797,7400.1%
Innoviva Inc(INVA)COM45781M101$79.5K6,414,0000.0%
Mersana Therapeutics IncCOM59045L106$77.9K2,927,0000.0%
Sarissa Capital Acquisitn CoW EXP 10/23/202G7823W110$5.0K3,333,3330.0%
Regulus Therapeutics IncCOM NEW75915K200$2.5K1,851,8510.0%
Mirati Therapeutics Inc(MRTXEUR)COM60468T105$2191,0000.0%
Intercept Pharmaceuticals Inc(ICPTUSD)COM45845P108$239500.0%